Pages that link to "Q34340198"
Jump to navigation
Jump to search
The following pages link to Pegylation: a novel process for modifying pharmacokinetics (Q34340198):
Displaying 50 items.
- PEGylation of Interferon-β-1a (Q22241420) (← links)
- Profile of certolizumab and its potential in the treatment of psoriatic arthritis (Q22305856) (← links)
- PEGylated Adenoviruses: From Mice to Monkeys (Q24635276) (← links)
- Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein (Q24814238) (← links)
- Nanocarriers Usage for Drug Delivery in Cancer Therapy (Q26740048) (← links)
- Immunogenicity of biotherapy used in psoriasis: the science behind the scenes (Q26827399) (← links)
- Protein corona - from molecular adsorption to physiological complexity (Q26853351) (← links)
- Interferons, Interferon Inducers, and Interferon-Ribavirin in Treatment of Flavivirus-Induced Encephalitis in Mice (Q27473398) (← links)
- New developments in the treatment of hepatitis C (Q27477964) (← links)
- Liposomes as nanomedical devices (Q28088315) (← links)
- Rational design and engineering of therapeutic proteins (Q28182762) (← links)
- The mechanism of action of interferon-β in relapsing multiple sclerosis (Q28239752) (← links)
- Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery (Q28396383) (← links)
- Glycoengineering of interferon-β 1a improves its biophysical and pharmacokinetic properties (Q28539087) (← links)
- Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview. (Q30235581) (← links)
- Therapeutic alpha-interferons protein: structure, production, and biosimilar. (Q30361968) (← links)
- Review on photoacoustic imaging of the brain using nanoprobes (Q30366218) (← links)
- Mechanistic and quantitative insight into cell surface targeted molecular imaging agent design. (Q30383551) (← links)
- Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study (Q30406070) (← links)
- Gastrointestinal biodurability of engineered nanoparticles: Development of an in vitro assay (Q30431391) (← links)
- Preclinical molecular imaging of tumor angiogenesis. (Q30475818) (← links)
- 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression (Q30497615) (← links)
- Intracellular Trafficking and Subcellular Distribution of a Large Array of HPMA Copolymers (Q30502459) (← links)
- A brain-sparing diphtheria toxin for chemical genetic ablation of peripheral cell lineages. (Q30844300) (← links)
- Contrast-enhanced MRI-guided photodynamic cancer therapy with a pegylated bifunctional polymer conjugate (Q33347186) (← links)
- An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel pegylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects (Q33412963) (← links)
- Immunogenicity and other problems associated with the use of biopharmaceuticals (Q33416851) (← links)
- Safety, Tolerability, and Immunogenicity of Interferons (Q33435810) (← links)
- A Bayesian Approach for Population Pharmacokinetic Modeling of Pegylated Interferon α-2a in Hepatitis C Patients. (Q33440863) (← links)
- PEGylation of interleukin-10 for the mitigation of enhanced pain states (Q33505369) (← links)
- Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa (Q33559298) (← links)
- Design, synthesis, characterization and in-vivo activity of a novel salmon calcitonin conjugate containing a novel PEG-lipid moiety. (Q33582600) (← links)
- Deciphering the kinetic binding mechanism of dimeric ligands using a potent plasma-stable dimeric inhibitor of postsynaptic density protein-95 as an example. (Q33615585) (← links)
- Toward a molecular understanding of nanoparticle-protein interactions (Q33639595) (← links)
- Polyethylene glycol (PEG) linked to near infrared (NIR) dyes conjugated to chimeric anti-carcinoembryonic antigen (CEA) antibody enhances imaging of liver metastases in a nude-mouse model of human colon cancer (Q33654731) (← links)
- Evaluation of in vitro cytotoxic activity of mono-PEGylated StAP3 (Solanum tuberosum aspartic protease 3) forms. (Q33783104) (← links)
- Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery (Q33805083) (← links)
- PVA and BSA stabilized silver nanoparticles based surface–enhanced plasmon resonance probes for protein detection (Q33844449) (← links)
- Tailoring polymersome bilayer permeability improves enhanced permeability and retention effect for bioimaging (Q33893586) (← links)
- Peginterferon-alpha2a (40 kDa) (Pegasys) for hepatitis B. (Q33989405) (← links)
- A coarse-grained model for polyethylene oxide and polyethylene glycol: conformation and hydrodynamics. (Q34120971) (← links)
- In situ growth of a PEG-like polymer from the C terminus of an intein fusion protein improves pharmacokinetics and tumor accumulation (Q34151598) (← links)
- Tumour therapy with radionuclides: assessment of progress and problems. (Q34185077) (← links)
- Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma (Q34225751) (← links)
- microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4) (Q34282774) (← links)
- PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice (Q34294045) (← links)
- Covalent IR820-PEG-diamine nanoconjugates for theranostic applications in cancer (Q34354141) (← links)
- Peginterferon-alpha-2a (40 kD): a review of its use in the management of chronic hepatitis C. (Q34481295) (← links)
- PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) (Q34490917) (← links)
- Interferon in the treatment of chronic hepatitis C: a drug caught between past and future. (Q34626479) (← links)